This study compares how two common treatments for bladder cancer, bladder-sparing therapy and surgery to remove the bladder, can affect patients' health, quality of life, and experiences, as well as the experiences of their caregivers.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT07225127.
Locations matching your search criteria
United States
Washington
Seattle
Fred Hutch/University of Washington/Seattle Children's Cancer ConsortiumStatus: Active
Contact: John L Gore
PRIMARY OBJECTIVES:
I. To compare patient-reported and patient-centered clinical outcomes between patients undergoing radical cystectomy and those receiving BST for recurrent high-grade NMIBC.
II. To characterize the heterogeneity of treatments received for recurrent high-grade NMIBC and corresponding patient and caregiver preferences.
III. To improve the prediction of progression to muscle invasive or metastatic bladder cancer in recurrent high-grade NMIBC using precision diagnostics for better-informed treatment decisions.
IV. To compare the impact of radical cystectomy and BST on caregivers of patients with recurrent high-grade NMIBC.
OUTLINE: This is an observational study. Participants are assigned to 1 of 2 cohorts.
COHORT I: Patients complete surveys, undergo archival tissue sample collection, and have their medical records reviewed on study. Patients may also complete an interview on study.
COHORT II: Caregivers complete surveys and may also complete an interview on study.
Trial PhaseNo phase specified
Trial TypeNot provided by clinicaltrials.gov
Lead OrganizationFred Hutch/University of Washington/Seattle Children's Cancer Consortium
Principal InvestigatorJohn L Gore